Related Experiment Video

Updated: Jun 6, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Host factors may influence response to antiviral therapy in chronic hepatitis B virus infections

Oliver Schildgen1

  • 1Kliniken der Stadt Köln, Institut für Pathologie, Private Universität Witten/Herdecke, Fakultät für Gesundheit, Ostmerheimer Str. 200, D-51109 Köln, Germany. schildgeno@kliniken-koeln.de

Medical Hypotheses
|December 1, 2010
PubMed

Insights

Chronic hepatitis B virus (HBV) infections persist despite treatments, leading to severe liver disease. This study explores host resistance mechanisms that cause antiviral therapy failure and aims to improve treatment strategies.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic hepatitis B virus (HBV) infection is a significant global health challenge, often leading to liver cirrhosis and hepatocellular carcinoma.
  • Current treatments, including antiviral drugs, face limitations due to emerging drug-resistant strains and complex host-related factors.
  • Co-infections, particularly with human immunodeficiency virus (HIV), exacerbate treatment challenges in chronic HBV.

Purpose of the Study:

  • To investigate the underlying host mechanisms contributing to resistance against antiviral therapy in chronic HBV infections.
  • To identify factors influencing therapy outcomes, especially in cases of HBV/HIV co-infection.
  • To provide a basis for optimizing antiviral therapies and mitigating the development of drug resistance.

Main Methods:

  • This article presents a hypothesis-driven analysis of existing literature.
  • It focuses on identifying potential host-related factors influencing antiviral drug efficacy.
  • The study synthesizes current knowledge on host-pathogen interactions in chronic HBV.

Main Results:

  • Antiviral drug resistance is a significant issue in chronic HBV treatment.
  • Host immune mechanisms and genetic factors appear to play a crucial role in treatment outcomes.
  • These host factors can contribute to therapy failure, even with effective antiviral agents.

Conclusions:

  • Understanding host resistance mechanisms is critical for improving chronic HBV treatment.
  • Further research into host-pathogen interactions is needed to overcome therapy failures.
  • Optimizing treatment strategies requires a comprehensive approach addressing both viral and host factors to reduce resistance.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...